As of 2025-06-26, the Fair Value of Pacira Biosciences Inc (PCRX) is -51.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 23.91 USD, the upside of Pacira Biosciences Inc is -313.97%.
With the market price of 23.91 USD and our fair value calculation, Pacira Biosciences Inc (PCRX) is not a good investment. Investing in PCRX stocks now will result in a potential loss of 313.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 145.50 | 42.00 | 15.90 | 41.96 | -99.56 | 29.16 |
| YoY growth | 1,422.73% | -71.13% | -62.14% | 163.87% | -337.30% | 223.20% |
| Market Cap (mil) | 1,107.03 |
| P/E | |
| Forward P/E |
| EPS | -2.05 |
| Avg earnings growth rate | 223.20% |
| TTM earnings | -94.75 |